Hepatic fibrosis

Common Name(s)

Hepatic fibrosis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatic fibrosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatic fibrosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hepatic fibrosis" returned 362 free, full-text research articles on human participants. First 3 results:

EFFECT OF RUANGANJIEDU DECOCTION INHIBIT EXPERIMENTAL HEPATIC FIBROSIS OF RATS.
 

Author(s): Sheng Liu, Xiao-Min Wang, Guo-Wang Yang

Journal:

 

RuanGanJieDu (RGJD) is a traditional Chinese medicine comprising nine Chinese medicinal herbs. The clinical use of RGJD by us was found that it has a good control effect on hepatic fibrosis (HF) patient. In order to further investigate the Anti-fibrosis mechanism of RGJD, hence this ...

Last Updated: 8 May 2017

Go To URL
Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.
 

Author(s): Rie Ibusuki, Hirofumi Uto, Kohei Oda, Akihiko Ohshige, Kazuaki Tabu, Seiichi Mawatari, Kotaro Kumagai, Shuji Kanmura, Tsutomu Tamai, Akihiro Moriuchi, Hirohito Tsubouchi, Akio Ido

Journal:

 

Neutrophil infiltration of the liver is a typical feature of alcoholic liver injury. Human neutrophil peptide (HNP)-1 is an antimicrobial peptide secreted by neutrophils. The aim of this study was to determine if HNP-1 affects ethanol-induced liver injury and to examine the mechanism ...

Last Updated: 13 Apr 2017

Go To URL
Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation.
 

Author(s): Xiaopeng Tian, Chunhong Zhao, Jinbo Guo, Shurui Xie, Fengrong Yin, Xiaoxia Huo, Xiaolan Zhang

Journal: Biomed Res Int. 2017 ;2017():4612769.

 

Background. The sympathetic nervous system (SNS) is responsible for hepatic stellate cells (HSCs) activation and the accumulation of collagen that occurs in hepatic fibrogenesis. Carvedilol has been widely used for the complication of hepatic cirrhosis in the clinic. Furthermore, ...

Last Updated: 11 Apr 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hepatic fibrosis" returned 61 free, full-text review articles on human participants. First 3 results:

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
 

Author(s): Chong-Yang Zhang, Wei-Gang Yuan, Pei He, Jia-Hui Lei, Chun-Xu Wang

Journal: World J. Gastroenterol.. 2016 Dec;22(48):10512-10522.

 

Liver fibrosis is a reversible wound-healing process aimed at maintaining organ integrity, and presents as the critical pre-stage of liver cirrhosis, which will eventually progress to hepatocellular carcinoma in the absence of liver transplantation. Fibrosis generally results from ...

Last Updated: 13 Jan 2017

Go To URL
Hepatic steatosis and fibrosis: Non-invasive assessment.
 

Author(s): Rustam N Karanjia, Mary M E Crossey, I Jane Cox, Haddy K S Fye, Ramou Njie, Robert D Goldin, Simon D Taylor-Robinson

Journal: World J. Gastroenterol.. 2016 Dec;22(45):9880-9897.

 

Chronic liver disease is a major cause of morbidity and mortality worldwide and usually develops over many years, as a result of chronic inflammation and scarring, resulting in end-stage liver disease and its complications. The progression of disease is characterised by ongoing inflammation ...

Last Updated: 26 Dec 2016

Go To URL
Evidence for a "Pathogenic Triumvirate" in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease.
 

Author(s): Lu Jiang, Pingping Fang, James L Weemhoff, Udayan Apte, Michele T Pritchard

Journal: Biomed Res Int. 2016 ;2016():4918798.

 

Autosomal recessive polycystic kidney disease (ARPKD) is a severe monogenic disorder that occurs due to mutations in the PKHD1 gene. Congenital hepatic fibrosis (CHF) associated with ARPKD is characterized by the presence of hepatic cysts derived from dilated bile ducts and a robust, ...

Last Updated: 28 Nov 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

S-Shearwave Elastography for Assessment of Hepatic Fibrosis
 

Status: Not yet recruiting

Condition Summary: Liver Fibroses

 

Last Updated: 8 Feb 2017

Go to URL
Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
 

Status: Recruiting

Condition Summary: Chronic Hepatitis B; Hepatic Fibrosis; Fatty Liver

 

Last Updated: 13 Oct 2016

Go to URL
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
 

Status: Recruiting

Condition Summary: Liver Fibrosis

 

Last Updated: 12 Jan 2016

Go to URL